发明名称 ANTI-IL-33 ANTIBODIES AND USES THEREOF
摘要 The present invention provides antibodies that bind to interleukin-33 (IL-33) and methods of using the same. The invention includes antibodies that inhibit or attenuate IL-33-mediated signaling. The antibodies of the invention may function to block the interaction between IL-33 and ST2. Alternatively, certain antibodies of the invention inhibit or attenuate IL-33-mediated signaling without blocking the IL-33/ST2 interaction. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human IL-33 with high affinity. The antibodies of the invention are useful for the treatment of diseases and disorders associated with IL-33 signaling and/or IL-33 cellular expression, such as inflammatory diseases, or allergic diseases.
申请公布号 US2014271658(A1) 申请公布日期 2014.09.18
申请号 US201414205512 申请日期 2014.03.12
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Murphy Andrew J.;Papadopoulos Nicholas J.;Orengo Jamie M.
分类号 C07K16/24;A61K31/137;A61K45/06;A61K39/395 主分类号 C07K16/24
代理机构 代理人
主权项 1. An isolated human monoclonal antibody or antigen-binding fragment thereof that binds human interleukin 33 (IL-33), wherein the antibody or antigen-binding fragment thereof inhibits or attenuates IL-33-mediated signaling.
地址 Tarrytown NY US